JP2018535191A5 - - Google Patents

Download PDF

Info

Publication number
JP2018535191A5
JP2018535191A5 JP2018515605A JP2018515605A JP2018535191A5 JP 2018535191 A5 JP2018535191 A5 JP 2018535191A5 JP 2018515605 A JP2018515605 A JP 2018515605A JP 2018515605 A JP2018515605 A JP 2018515605A JP 2018535191 A5 JP2018535191 A5 JP 2018535191A5
Authority
JP
Japan
Prior art keywords
dendritic cells
stimulated
cell
cancer
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2018515605A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018535191A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/053554 external-priority patent/WO2017053873A1/en
Publication of JP2018535191A publication Critical patent/JP2018535191A/ja
Publication of JP2018535191A5 publication Critical patent/JP2018535191A5/ja
Priority to JP2021155820A priority Critical patent/JP2022023061A/ja
Ceased legal-status Critical Current

Links

JP2018515605A 2015-09-26 2016-09-23 樹状細胞を産生するための組成物及び方法 Ceased JP2018535191A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021155820A JP2022023061A (ja) 2015-09-26 2021-09-24 樹状細胞を産生するための組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562284434P 2015-09-26 2015-09-26
US62/284,434 2015-09-26
PCT/US2016/053554 WO2017053873A1 (en) 2015-09-26 2016-09-23 Compositions and methods for producing dendritic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021155820A Division JP2022023061A (ja) 2015-09-26 2021-09-24 樹状細胞を産生するための組成物及び方法

Publications (2)

Publication Number Publication Date
JP2018535191A JP2018535191A (ja) 2018-11-29
JP2018535191A5 true JP2018535191A5 (enExample) 2019-10-03

Family

ID=58387383

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018515605A Ceased JP2018535191A (ja) 2015-09-26 2016-09-23 樹状細胞を産生するための組成物及び方法
JP2021155820A Pending JP2022023061A (ja) 2015-09-26 2021-09-24 樹状細胞を産生するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021155820A Pending JP2022023061A (ja) 2015-09-26 2021-09-24 樹状細胞を産生するための組成物及び方法

Country Status (7)

Country Link
US (2) US10765727B2 (enExample)
EP (2) EP3865150A1 (enExample)
JP (2) JP2018535191A (enExample)
CN (1) CN108291205A (enExample)
CA (1) CA2999881A1 (enExample)
MX (1) MX2018003757A (enExample)
WO (1) WO2017053873A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3316897A4 (en) 2015-07-02 2019-03-13 Primevax Immuno-Oncology, Inc. COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
JP2018535191A (ja) 2015-09-26 2018-11-29 プライムヴァックス イミュノ−オンコロジー,インク. 樹状細胞を産生するための組成物及び方法
JP2020500847A (ja) 2016-11-16 2020-01-16 プライムヴァックス イミュノ−オンコロジー,インク. 癌の処置のための併用免疫療法
CA3049225A1 (en) 2017-01-04 2018-07-12 PrimeVax Immuno-Oncology, Inc. Compositions and methods for therapy with dengue virus
MX2019015194A (es) * 2017-06-15 2020-08-03 Primevax Immuno Oncology Inc Composiciones y métodos para terapia de cáncer con virus de dengue y células dendríticas.
CN109096386A (zh) * 2018-08-31 2018-12-28 上海莱馥生命科学技术有限公司 一种乳腺癌干细胞抗原的制备方法和应用
CN109609452A (zh) * 2018-12-27 2019-04-12 青岛麦迪赛斯生物科技有限公司 一种高效的巨噬细胞体外制备方法
CN109781977B (zh) * 2019-01-09 2022-03-29 首都医科大学附属北京安定医院 IL15Rα以及相关膜蛋白检测试剂盒及其应用
CN116333969A (zh) * 2023-02-01 2023-06-27 宁波荣安生物药业有限公司 一种狂犬病毒用Vero细胞培养方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
WO1999042564A2 (en) 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
US6048686A (en) 1998-05-05 2000-04-11 Randy Kyle Brown Hyperthermia and immunotherapy for cancer
US6524587B1 (en) * 1998-05-05 2003-02-25 Bruce W. Lyday Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors
US6511667B1 (en) 1999-03-26 2003-01-28 The United States Of America As Represented By The Secretary Of The Army Attenuated dengue-2 virus vaccine
DE60041250D1 (de) 1999-03-26 2009-02-12 Us Army Multivalenter dengue-virus impfstoff
EP1168924A4 (en) 1999-03-31 2002-09-04 Univ Pittsburgh DERIVATIVED IMMUNOGENES IN VITRO INDUCTION OF ANTIQUE-SPECIFIC T-CELLS USING DENDRITIC CELL-TUMOR CELL OR DENDRITIC CELL-VIRAL CELL
EP1484064A1 (en) 2003-06-04 2004-12-08 Gesellschaft für Biotechnologische Forschung Therapeutical composition containing dentritic cells and use thereof
CA2571849A1 (en) * 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having rna virus transferred thereinto
US8513008B2 (en) * 2004-10-07 2013-08-20 Argos Therapeutics, Inc. Mature dendritic cell compositions and methods for culturing same
EP2589602B1 (en) 2006-08-15 2016-04-06 The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health Development of dengue virus vaccine components
WO2013188315A1 (en) 2012-06-10 2013-12-19 Inviragen, Inc. Compositions and methods for administration of vaccines against dengue virus
CA2793458A1 (en) * 2010-03-15 2011-09-22 The Trustees Of The University Of Pennsylvania System and method of preparing and storing activated mature dendritic cells
PE20140646A1 (es) 2011-05-26 2014-05-29 Glaxosmithkline Biolog Sa Vacuna de virus de dengue inactivado
CN104244975A (zh) * 2012-03-02 2014-12-24 埃斯特韦实验室有限公司 用于制备树突细胞疫苗的方法
WO2013154778A1 (en) 2012-04-11 2013-10-17 Dana-Farber Cancer Institute, Inc. Host targeted inhibitors of dengue virus and other viruses
CA2939093A1 (en) 2014-02-14 2015-08-20 Immune Design Corp. Immunotherapy of cancer through combination of local and systemic immune stimulation
AU2016259020B2 (en) 2015-05-07 2021-12-09 Baylor College Of Medicine Dendritic cell immunotherapy
EP3316897A4 (en) 2015-07-02 2019-03-13 Primevax Immuno-Oncology, Inc. COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
JP2018535191A (ja) 2015-09-26 2018-11-29 プライムヴァックス イミュノ−オンコロジー,インク. 樹状細胞を産生するための組成物及び方法
JP2020500847A (ja) 2016-11-16 2020-01-16 プライムヴァックス イミュノ−オンコロジー,インク. 癌の処置のための併用免疫療法
CA3049225A1 (en) 2017-01-04 2018-07-12 PrimeVax Immuno-Oncology, Inc. Compositions and methods for therapy with dengue virus
MX2019015194A (es) 2017-06-15 2020-08-03 Primevax Immuno Oncology Inc Composiciones y métodos para terapia de cáncer con virus de dengue y células dendríticas.

Similar Documents

Publication Publication Date Title
JP2018535191A5 (enExample)
USD754375S1 (en) Headlight for a vehicle
USD740724S1 (en) Radiator grill for a vehicle
MX373228B (es) Formulaciones piretroides.
JP2018064407A5 (enExample)
WO2014122035A3 (en) Induced dendritic cells and uses thereof
JP2011527428A5 (enExample)
HK1204275A1 (en) Method for the preparation of dendritic cell vaccines
JP2017047613A5 (enExample)
JP2015518492A5 (enExample)
PH12016501689A1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
WO2017041114A3 (en) Anti-nicotinamide phosphoribosyltransferase antibody genes and methods of use thereof
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
WO2014166084A8 (en) Mutant vaccinia virus strains, uses thereof and method of producing the same
Skrypnyk Non-skew-symmetric classical r-matrices and integrable “px+ ipy” proton–neutron BCS models
MX360120B (es) Produccion de virus infecciosos de influenza.
TWD178434S (zh) 眼鏡(二)
CN204130011U (zh) 大学数学教学使用的马鞍面演示教具
TWD183236S (zh) 眼鏡(十四)
TWD184324S (zh) 眼鏡(十三)
CN204797017U (zh) Pelican机架箱单人背负装置
JP2015044795A5 (ja) トリフルオロフェニル誘導体
Hull Inspiring the Next Generation I
JP2014111631A5 (enExample)
Carreteiro The meaning of civil service appeal for Brazilian youngsters